News

Just a week had remained before scientists in South Africa were to begin clinical trials of an HIV vaccine, and hopes were ...
In the closing of the recent trading day, Novavax (NVAX) stood at $6.97, denoting a +1.9% move from the preceding trading day.
Zacks Investment Research on MSN6d
Is Trending Stock Novavax, Inc. (NVAX) a Buy Now?
Novavax (NVAX) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
In a July 9 memo, the director of the FDA's Center for Biologics Evaluation and Research contended there was not enough ...
Just days before South African scientists were set to launch clinical trials of a promising HIV vaccine, their progress was abruptly halted. An email landed in their inboxes, brief and devastating: ...
A former Pfizer Inc. scientist denied an allegation made by House Republicans that he conspired to delay the release of Covid ...
Vinay Prasad overruled other reviewers for a third time in recent months in clearing only narrow use of Moderna's vaccine in ...
Ongoing advancements and investments are reshaping Virginia's biotechnology landscape, but what breakthroughs lie ahead for ...